Serum Renalase Levels Correlate with Disease Activity in Lupus Nephritis

• Published in: PloS one Vol. 10; no. 10; p. e0139627
• Main Authors: Qi, Chaojun, Wang, Ling, Zhang, Minfang, Shao, Xinghua, Chang, Xinbei, Fan, Zhuping, Cao, Qin, Mou, Shan, Wang, Qin, Yan, Yucheng, Desir, Gary, Ni, Zhaohui
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 02.10.2015; Public Library of Science (PLoS)
• Subjects: Active control; Adult; Autoimmune diseases; Biological markers; Biomarkers - blood; Care and treatment; Case-Control Studies; Cell survival; Chronic conditions; Complications; Correlation; Cross-Sectional Studies; Deoxyribonucleic acid; Diabetes; Diagnosis; Disease Progression; DNA; Enzyme-linked immunosorbent assay; Excretion; Female; Gene expression; Health aspects; Heart; Hospitals; Humans; Immunohistochemistry; Infiltration; Inflammation; Kidney diseases; Kidneys; Liver cancer; Lupus; Lupus nephritis; Lupus Nephritis - blood; Lupus Nephritis - pathology; Macrophages; Male; Medicine; Middle Aged; Monoamine Oxidase - blood; Morbidity; Nephritis; Nephrology; Pathogenesis; Patients; Physiological aspects; Rheumatology; Serum albumin; Studies; Systemic lupus erythematosus; Urine; United States; China; United States > US; Connecticut
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0139627

Lupus nephritis (LN) is among the most serious complications of systemic lupus erythematosus (SLE), which causes significant morbidity and mortality. Renalase is a novel, kidney-secreted cytokine-like protein that promotes cell survival. Here, we aimed to investigate the relationship of serum renalase levels with LN and its role in the disease progression of LN. For this cross-sectional study, 67 LN patients and 35 healthy controls were enrolled. Seventeen active LN patients who received standard therapies were followed up for six months. Disease activity was determined by the SLE Disease Activity-2000 (SLEDAI-2K) scoring system and serum renalase amounts were determined by ELISA. Predictive value of renalase for disease activity was assessed. Furthermore, the expression of renalase in the kidneys of patients and macrophage infiltration was assessed by immunohistochemistry. Serum renalase amounts were significantly higher in LN patients than in healthy controls. Moreover, patients with proliferative LN had more elevated serum renalase levels than Class V LN patients. In proliferative LN patients, serum renalase levels were significantly higher in patients with active LN than those with inactive LN. Serum renalase levels were positively correlated with SLEDAI-2K, 24-h urine protein excretion, ds-DNA and ESR but inversely correlated with serum albumin and C3. Renalase amounts decreased significantly after six-months of standard therapy. The performance of renalase as a marker for diagnosis of active LN was 0.906 with a cutoff value of 66.67 μg/ml. We also observed that the amount of renalase was significantly higher in glomerular of proliferative LN along with the co-expression of macrophages. Serum renalase levels were correlated with disease activity in LN. Serum renalase might serve as a potential indicator for disease activity in LN. The marked increase of glomerular renalase and its association with macrophages suggest that it might play an important role in disease progression of LN.